ARTICLE | Clinical News
LJP 394 Toleragens molecule: Filed an IND
August 8, 1994 7:00 AM UTC
La Jolla Pharmaceutical Co. (LJPC), San Diego Product: LJP 394 Toleragens molecule, which shuts off B cells that produce antibodies Indication: Lupus Status: Filed an IND ...